These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility. Walter SD; Han H; Briel M; Guyatt GH Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155 [TBL] [Abstract][Full Text] [Related]
3. Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands. van den Bogert CA; Souverein PC; Brekelmans CTM; Janssen SWJ; Koëter GH; Leufkens HGM; Bouter LM J Clin Epidemiol; 2017 Aug; 88():140-147. PubMed ID: 28487159 [TBL] [Abstract][Full Text] [Related]
4. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules. Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M; J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993 [TBL] [Abstract][Full Text] [Related]
5. Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination. Williams RJ; Tse T; DiPiazza K; Zarin DA PLoS One; 2015; 10(5):e0127242. PubMed ID: 26011295 [TBL] [Abstract][Full Text] [Related]
6. Early Termination of Acute Stroke Randomized Controlled Trials Published Between 2013 and 2020: A Systematic Review. Strong B; Oostema JA; Nikroo N; Hussain M; Reeves MJ Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007995. PubMed ID: 34932376 [TBL] [Abstract][Full Text] [Related]
7. Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early. Shimura M; Maruo K; Gosho M Pharm Stat; 2018 Sep; 17(5):400-413. PubMed ID: 29687592 [TBL] [Abstract][Full Text] [Related]
8. Predictors of premature termination of cardiac surgery trials: insights from the Clinicaltrial.gov database. Cancelli G; Rossi CS; Dell'Aquila M; Mantaj P; Hirofuji A; Soletti G; Harik L; Cangut B; Al Zaghari T; Leith J; Falco G; Ibrahim M; Dimagli A; Rahouma M; Gaudino MFL Eur J Cardiothorac Surg; 2024 Aug; 66(2):. PubMed ID: 39133169 [TBL] [Abstract][Full Text] [Related]
9. The dangers of stopping a trial too early. Briel M; Bassler D; Wang AT; Guyatt GH; Montori VM J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():56-60. PubMed ID: 22810449 [TBL] [Abstract][Full Text] [Related]
10. Data monitoring committees, interim analysis and early termination in paediatric trials. Fernandes RM; van der Lee JH; Offringa M Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998 [TBL] [Abstract][Full Text] [Related]
11. Reducing overestimation of the treatment effect by interim analysis when designing clinical trials. Shimura M J Clin Pharm Ther; 2019 Apr; 44(2):243-248. PubMed ID: 30414384 [TBL] [Abstract][Full Text] [Related]
12. Interim analyses and early termination of clinical trials. Choi SC J Biopharm Stat; 1997 Nov; 7(4):533-43. PubMed ID: 9358327 [TBL] [Abstract][Full Text] [Related]
13. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research. Wang H; Rosner GL; Goodman SN Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682 [TBL] [Abstract][Full Text] [Related]
14. Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III Trials. Guinn D; Wilhelm EE; Shoulson I Ther Innov Regul Sci; 2020 Jan; 54(1):232-239. PubMed ID: 32008239 [TBL] [Abstract][Full Text] [Related]
15. Information time scales for interim analyses of randomized clinical trials. Freidlin B; Othus M; Korn EL Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947 [TBL] [Abstract][Full Text] [Related]
16. Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritis. Smith CL; Jin Y; Raddad E; McNearney TA; Ni X; Monteith D; Brown R; Deeg MA; Schnitzer T Pharm Stat; 2019 Jan; 18(1):39-53. PubMed ID: 30321909 [TBL] [Abstract][Full Text] [Related]
17. Stopping clinical trials early for futility: retrospective analysis of several randomised clinical studies. Jitlal M; Khan I; Lee SM; Hackshaw A Br J Cancer; 2012 Sep; 107(6):910-7. PubMed ID: 22878376 [TBL] [Abstract][Full Text] [Related]
18. Increasing the efficiency of clinical trials in neurodegenerative disorders using group sequential trial designs. van Eijk RPA; Nikolakopoulos S; Ferguson TA; Liu D; Eijkemans MJC; van den Berg LH J Clin Epidemiol; 2018 Jun; 98():80-88. PubMed ID: 29486281 [TBL] [Abstract][Full Text] [Related]
19. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications. Alturki R; Schandelmaier S; Olu KK; von Niederhäusern B; Agarwal A; Frei R; Bhatnagar N; Hooft L; von Elm E; Briel M J Clin Epidemiol; 2017 Jan; 81():56-63. PubMed ID: 27614277 [TBL] [Abstract][Full Text] [Related]
20. Monitoring a randomized clinical trial for futility: the north-Norwegian lidocaine intervention trial. Berntsen RF; Rasmussen K; Bjørnstad JF Stat Med; 1991 Mar; 10(3):405-12. PubMed ID: 2028124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]